Literature DB >> 16490317

Involvements of mu- and kappa-opioid receptors in morphine-induced antinociception in the nucleus accumbens of rats.

Wei Xiong1, Long-Chuan Yu.   

Abstract

It is well known that there are three types of opioid receptors, mu- (MOR), delta- (DOR), and kappa-opioid receptor (KOR) in the central nervous system. The present study investigated the involvement of opioid receptors in morphine-induced antinociception in the nucleus accumbens (NAc) of rats. The hindpaw withdrawal latencies to thermal and mechanical stimulation increased markedly after intra-NAc administration of morphine. The antinociceptive effects induced by morphine were dose-dependently inhibited by intra-NAc administration of the non-selective opioid receptor antagonist naloxone. Furthermore, the morphine-induced antinociception was significantly attenuated by subsequent intra-NAc injection of the MOR antagonist beta-funaltrexamine or the KOR antagonist nor-binaltorphimine, but not the DOR antagonist naltrindole. The results indicate that MOR and KOR, but not DOR are involved in the morphine-induced antinociception in the NAc of rats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16490317     DOI: 10.1016/j.neulet.2006.01.052

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

2.  Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens.

Authors:  N Kabli; T Nguyen; G Balboni; B F O'Dowd; S R George
Journal:  Mol Psychiatry       Date:  2013-09-24       Impact factor: 15.992

3.  A reply to Wang T, Shan L, Du L, Feng J, Xu Z, Staal WG, Jia F. Serum concentration of 25-hydroxyvitamin D in autism spectrum disorder: a systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2015; doi: 10.1007/s00787-015-0786-1.

Authors:  Keith Fluegge
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-12-10       Impact factor: 4.785

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.